Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2018 | Genomic advancements in non-malignant hematology

Willem Ouwehand • 16 Apr 2018
BSH 2018
General

Willem Ouwehand, MD, PhD, of the University of Cambridge, Cambridge, UK, discusses non-malignant hematology, particularly rare inherited disorders of hematopoietic stem cells and of the coagulation. He notes the culture of data sharing that has been predominant over the last few years, not just within the UK, but internationally, between consultant hematologists. Subsequently, this joint effort has facilitated molecular diagnoses for thousands of patients. Moreover, he applauds the efforts of the 100,000 Genomes Project, in so far as integrating genomics to the bedside. This video was recorded at the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, held in Liverpool, UK.

More from Willem Ouwehand

1:45
Integrating genomics into clinical hematology
Willem Ouwehand • 16 Apr 2018
1:06
Clinical hematology: moving forward
Willem Ouwehand • 16 Apr 2018

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals